- Home
- WHLRD vs GALT Comparison
WHLRD vs GALT Comparison
Compare WHLRD & GALT Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- WHLRD
- GALT
- Stock Information
- Founded
- WHLRD N/A
- GALT 2000
- Country
- WHLRD United States
- GALT United States
- Employees
- WHLRD 52
- GALT N/A
- Industry
- WHLRD Real Estate Investment Trusts
- GALT Biotechnology: Pharmaceutical Preparations
- Sector
- WHLRD Real Estate
- GALT Health Care
- Exchange
- WHLRD Nasdaq
- GALT Nasdaq
- Market Cap
- WHLRD N/A
- GALT 54.6M
- IPO Year
- WHLRD N/A
- GALT N/A
- Fundamental
- Price
- WHLRD $26.60
- GALT $1.18
- Analyst Decision
- WHLRD
- GALT Hold
- Analyst Count
- WHLRD 0
- GALT 1
- Target Price
- WHLRD N/A
- GALT N/A
- AVG Volume (30 Days)
- WHLRD N/A
- GALT 1.6M
- Earning Date
- WHLRD N/A
- GALT 11-13-2024
- Dividend Yield
- WHLRD N/A
- GALT N/A
- EPS Growth
- WHLRD N/A
- GALT N/A
- EPS
- WHLRD N/A
- GALT N/A
- Revenue
- WHLRD N/A
- GALT N/A
- Revenue This Year
- WHLRD N/A
- GALT N/A
- Revenue Next Year
- WHLRD N/A
- GALT N/A
- P/E Ratio
- WHLRD N/A
- GALT N/A
- Revenue Growth
- WHLRD N/A
- GALT N/A
- 52 Week Low
- WHLRD N/A
- GALT $0.73
- 52 Week High
- WHLRD N/A
- GALT $4.27
- Technical
- Relative Strength Index (RSI)
- WHLRD 57.89
- GALT 29.90
- Support Level
- WHLRD $24.99
- GALT $0.76
- Resistance Level
- WHLRD $26.40
- GALT $1.47
- Average True Range (ATR)
- WHLRD 0.71
- GALT 0.25
- MACD
- WHLRD 0.11
- GALT -0.09
- Stochastic Oscillator
- WHLRD 100.00
- GALT 22.70
About WHLRD Wheeler Real Estate Investment Trust Inc.
Wheeler Real Estate Investment Trust Inc is a self-managed commercial real estate investment company. It owns, leases, and operates income-producing retail properties with a primary focus on grocery-anchored centers. The company's properties include Alex City Marketplace in Alexander City, Alabama; Bryan Station in Lexington, Kentucky; Cardinal Plaza in Henderson, North Carolina; Clover Plaza in Clover, South Carolina; Winslow Plaza in Sicklerville, New Jersey and many more.
About GALT Galectin Therapeutics Inc.
Galectin Therapeutics Inc is a clinical-stage biopharmaceutical company. The company focuses on drug research and development to create new therapies for fibrotic disease, cancer, and selected other diseases. Its galectin-3 inhibitor is belapectin (GR-MD-02), which has been demonstrated in preclinical models to reverse liver fibrosis and cirrhosis.